DATA & ANALYTICS
In an era defined by digital transformation, two industries stand at the forefront of technological advancement: semiconductors and biopharmaceuticals. Both require unprecedented precision, innovative manufacturing approaches and the ability to scale rapidly in response to global demand.
Fujifilm, drawing on its legacy in photographic film manufacturing, has positioned itself as a critical player in both sectors, leveraging its expertise in materials chemistry and zero-defect manufacturing to address the complex challenges facing these industries.
The convergence of these two fields might seem unlikely at first glance, yet they share fundamental requirements: extreme precision, uncompromising quality control and the ability to work with highly sensitive materials at microscopic scales. As global demand for both advanced chips and life-saving medicines surges, Fujifilm’ s dual expertise positions it uniquely to serve as a critical enabler of progress in both domains.
US $ 3.7bn
Total investment in Fujifilm Biotechnologies CDMO capabilities and US expansion
technologymagazine. com 223